| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |